What do we know about the Moderna vaccine?

A scientist working on the Moderna coronavirus vaccine (Moderna/PA)

US company Moderna said its coronavirus vaccine offers high levels of protection, that trials have shown no serious safety concerns and that it is applying for regulatory approval.

The phase three results suggest vaccine efficacy against the disease was 94.1%, and vaccine efficacy against severe Covid-19 was 100%.